Jefferies Group's position in Boston Scientific is currently worth $680k. That's 0.01% of their equity portfolio (765th largest holding). The first Boston Scientific trade was made in Q2 2018. Since then Jefferies Group bought shares seven more times and sold shares on eight occasions. The investor's estimated purchase price is $966k, resulting in a loss of 30%.
Active Energy Group PLC (AIM:AEG, OTCQB:ATGVF) said its shares have moved from the OTCQB Venture Market to the OTC Integrated Disclosure Market in the...
Jefferies Financial Group Inc. boosted its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 124.3% in the second quarter, according to the compa...
With their robustness and growth potential, healthcare stocks are becoming a focal point in portfolios worldwide. Moreover, the U.S. stands out at the forefr...
Any physician that implants a Boston Scientific’s marlex mid-urethral sling is exposed to big legal problems